Mixed lymphocyte reaction-conditioned MSC-derived extracellular vesicles enhance graft survival via miR-638-mediated immunoregulation
Stem Cells Translational Medicine · 22.04.2025 · 14 (4)
DOI: 10.1093/stcltm/szaf009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 22.04.2025. Verfasst von Yue Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Transplantation, Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University), 200003 Shanghai, People's…. Hauptthemen laut MEDLINE: Extracellular Vesicles, MicroRNAs, Mesenchymal Stem Cells, Graft Survival. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Shanghai, National Natural Science Grant of China, Pyramid Talent Project.
Abstract (Originalsprache)
Background
Mesenchymal stem cells (MSCs) require priming by proinflammatory stimuli for optimal immunosuppressive effects. Our previous work identified mixed lymphocyte reaction-conditioned medium (MLR-CdM) as a potent enhancer of MSC immunosuppressive properties. This study evaluates the immunomodulatory potential of MSC-derived extracellular vesicles preconditioned with MLR-CdM (MSC-EVMLR) compared to IFN-γ (MSC-EVIFN), focusing on key miRNAs and mechanisms involved.
Methods
We assessed the ability of MSC-EVMLR and MSC-EVIFN to modulate lymphocyte proliferation and cytokine expression in vitro. To identify potential effector molecules within MSC-EVMLR, we performed miRNA array analysis combined with dose-response experiments using MLR-CdM under varying stimulation conditions. We used a murine allogeneic heterotopic heart transplantation model to investigate the impact of MSC-EVMLR on graft survival and its immunomodulatory effects.
Results
MSC-EVMLR outperformed MSC-EVIFN in suppressing lymphocyte proliferation and steering cytokine expression toward an anti-inflammatory profile in vitro. Through miRNA array analysis and dose-response experiments with MLR-CdM, miR-638 was identified as a potential effector molecule in MSC-EVMLR. In vivo study demonstrated that MSC-EVMLR significantly prolonged graft survival, which was associated with a marked decreased proinflammatory cytokines IL6 and IFN-γ and increase in regulatory T cells (Tregs) and within the transplanted heart tissue. These effect was significantly reduced upon miR-638 knockdown. Additionally, the miR-638/Fosb axis was identified as a key pathway that promoted Treg differentiation and induced immune tolerance.
Conclusions
Preconditioning MSCs with MLR-CdM, a blend of inflammatory stimuli, potentiates the immunoregulatory capacity of MSC-EV beyond the effects of IFN-γ stimulation alone. This study advances the understanding of MSC-EV-based therapies in transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organ Transplantation, Shanghai Changzheng Hospital (Second Affiliated Hospital of Naval Medical University), 200003 Shanghai, People's Republic of China.
- Shanghai Heart Failure Research Center, Shanghai East Hospital, Tongji University School of Medicine, 200120 Shanghai, People's Republic of China.
- Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, 200120 Shanghai, People's Republic of China.
- Shanghai East Hospital, Jinzhou Medical University, 121001 Jinzhou, People's Republic of China.
ORCID-Profile: Xiaoting Liang
Förderung
- Natural Science Foundation of Shanghai
- National Natural Science Grant of China
- Pyramid Talent Project
Zitieren
APA
Ding, Y., Wang, J., Zheng, X., Chen, Y., Zhu, F., Lin, F., Ma, K., Liang, X., & Han, S. (2025). Mixed lymphocyte reaction-conditioned MSC-derived extracellular vesicles enhance graft survival via miR-638-mediated immunoregulation. Stem Cells Translational Medicine, 14(4). https://doi.org/10.1093/stcltm/szaf009
Vancouver
Ding Y, Wang J, Zheng X, Chen Y, Zhu F, Lin F, et al. Mixed lymphocyte reaction-conditioned MSC-derived extracellular vesicles enhance graft survival via miR-638-mediated immunoregulation. Stem Cells Translational Medicine. 2025;14(4). doi:10.1093/stcltm/szaf009
BibTeX
@article{Ding2025,
author = {Ding, Yue and Wang, Jiyuan and Zheng, Xueyang and Chen, Yu and Zhu, Fanyuan and Lin, Fang and Ma, Kexin and Liang, Xiaoting and Han, Shu},
title = {Mixed lymphocyte reaction-conditioned MSC-derived extracellular vesicles enhance graft survival via miR-638-mediated immunoregulation},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {4},
doi = {10.1093/stcltm/szaf009}
}
EUVIMED